Researchers set benchmarks for screening mammography
Sep 26, 2006, 23:10, Reviewed by: Dr. Rashmi Yadav
|The authors hope that their findings will allow radiologists to evaluate and improve the accuracy of their individual cancer detection rates when reading mammograms.
A recent study of medical audit data funded by the National Cancer Institute (NCI) revealed that community mammography screening results surpass performance recommendations across the United States. Approximately 188 mammography facilities nationwide contributed to the study of more than 1.1 million women, who underwent at least one screening mammography exam between 1996 and 2002.
"With a cancer detection rate of 4.8 per 1,000 women, our results show that most radiologists who are reading mammograms are performing well," said Robert D. Rosenberg, M.D., lead researcher and professor of radiology at the University of New Mexico in Albuquerque. "Mammography, combined with better breast cancer treatments, appears to be helping to decrease the number of deaths from breast cancer."
Up until now, there has been no national measurement with which radiologists could compare their individual cancer detection rates.
"There have been no data available for mammographers in the United States to give context to anyone's individual performance results. All prior guidelines were best guesses from a panel of experienced radiologists," Dr. Rosenberg explained.
In the study, data were collected from six NCI-funded research sites, for a total of nearly 2.6 million screening exams assessed by 807 radiologists. Each radiologist's assessment, along with every woman's outcome within 12 months of the initial screening exam, were tallied. The radiologists included in the analysis came from urban, rural, large and small practices of different organizational structures, across broad geographic areas.
Approximately 10 percent of mammograms yielded abnormal findings, for a recall rate of 9.8 percent.
"We found that radiologists are much more likely to err on the side of caution, for a higher recall rate," said co-author Bonnie Yankaskas, Ph.D., professor of radiology at the University of North Carolina at Chapel Hill.
After additional imaging work-up, cancer was ultimately diagnosed in 4.8 of 1,000 women. When a radiologist identified significantly abnormal findings and advised that biopsy be performed immediately, 34 percent of biopsy results yielded cancer.
The majority of women examined were 40 to 70 years old. Of all reported cancers, 21.6 percent proved to be ductal carcinoma in situ, and 78.4 percent were invasive cancers. Of invasive cancers, 37.2 percent were small tumors measuring 10 millimeters or less in diameter, 41.6 percent were mid-sized tumors measuring 11 to 20 millimeters, and 21.2 percent were large invasive tumors measuring 2 centimeters and larger.
The authors hope that their findings will allow radiologists to evaluate and improve the accuracy of their individual cancer detection rates when reading mammograms.
"Recalls and additional biopsies do add to the cost and anxiety of mammography," said Dr. Rosenberg. "However, we are continually working to improve the test from both ends--finding cancers while minimizing unnecessary work-ups."
- The findings are reported in the October issue of Radiology.
Radiology is a monthly scientific journal devoted to clinical radiology and allied sciences. The journal is edited by Anthony V. Proto, M.D., School of Medicine, Virginia Commonwealth University, Richmond, Va. Radiology is owned and published by the Radiological Society of North America, Inc. (RSNA.org/radiologyjnl)
The Radiological Society of North America (RSNA) is an association of more than 38,000 radiologists, radiation oncologists, medical physicists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill. (RSNA.org)
"Performance Benchmarks for Screening Mammography." Collaborating with Drs. Rosenberg and Yankaskas on this paper were Linn A. Abraham, M.S., Edward A. Sickles, M.D., Constance D. Lehman, M.D., Ph.D., Berta M. Geller, Ed.D., Patricia A. Carney, Ph.D., Karla Kerlikowske, M.D., Diana S. M. Buist, Ph.D., Donald L. Weaver, M.D., William E. Barlow, Ph.D., and Rachel Ballard-Barbash, M.D., M.P.H.
The data collected for this study were gathered by the Breast Cancer Surveillance Consortium, an initiative funded by the NCI.
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
Top of Page